This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Quillivant XR, a 25 mg/5 mL oral suspension medication, with a ceiling value of $2,522.22. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 23, 2024 with a completion date of December 24, 2024. This contract is a delivery order and is priced on a firm fixed-price basis. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/24/25, 9:44 AM